Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 USD | -3.21% |
|
-1.86% | -7.86% |
Business Summary
Number of employees: 23
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Treatments for Solid Tumor Cancers
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.35% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Oliviero
CEO | Chief Executive Officer | 48 | 15-10-12 |
William Gray
DFI | Director of Finance/CFO | 36 | 16-01-31 |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Director/Board Member | 68 | 14-11-09 | |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 14-11-09 | |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Christian Béchon
BRD | Director/Board Member | 63 | 18-10-15 |
Barry Salzman
BRD | Director/Board Member | 62 | 15-12-31 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 15-07-31 |
James Oliviero
CEO | Chief Executive Officer | 48 | 15-10-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 700,000 | 0 | 0 | 79.87 % |
Stock B | 1 | 36,216,279 | 29,485,050 ( 81.41 %) | 0 |
Company contact information
Checkpoint Therapeutics, Inc.
95 Sawyer Road Suite 110
02453, Waltham
+781 652 4500
http://www.checkpointtx.com![address Checkpoint Therapeutics, Inc.(CKPT)](https://cdn.zonebourse.com/static/address/35939980.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.86% | 80.35M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- CKPT Stock
- Company Checkpoint Therapeutics, Inc.